Maria Baryshnikova Selected Research

LCS1269

1/2017

Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Baryshnikova Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2017
1	Neoplasms (Cancer) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 07/2015

Drug/Important Bio-Agent (IBA)

1	human ERBB2 proteinIBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	PolymersIBA 01/2019
1	PolyelectrolytesIBA 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Drug CarriersIBA 01/2019
1	Chemokine CXCL12IBA 01/2017
1	aranozaIBA 01/2017
1	Alkylating AgentsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2017
1	LCS1269IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	SuspensionsIBA 07/2015

Therapy/Procedure

2	Quantum Dots (Quantum Dot) 01/2019 - 07/2015
1	Therapeutics 01/2017
1	Microspheres (Microsphere) 07/2015